Clinical Trial Update: Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis

View source ↗

Summary

A clinical trial update about a study evaluating antibodies to anti-TNF agents in Juvenile Idiopathic Arthritis. The trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Snippet

Sponsor: Blood Transfusion Centre of Slovenia | Conditions: Juvenile Idiopathic Arthritis | Status: UNKNOWN